找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Urticaria and Angioedema; Torsten Zuberbier,Clive Grattan,Marcus Maurer Book 2021Latest edition Springer Nature Switzerland AG 2021 Dermat

[復(fù)制鏈接]
樓主: 粗略
41#
發(fā)表于 2025-3-28 17:39:00 | 只看該作者
42#
發(fā)表于 2025-3-28 19:28:00 | 只看該作者
43#
發(fā)表于 2025-3-28 23:55:17 | 只看該作者
Angioedema,uation of treatment. Hereditary bradykinin AE (HAE) is of two types: either associated with a C1Inh deficiency or with a normal C1Inh. The diagnosis of HAE with normal C1Inh is based on the clinical and genetic mutation research on the . KNG1 and . genes. In the case of bradykinin AE, a specific tre
44#
發(fā)表于 2025-3-29 04:11:44 | 只看該作者
Antihistamines,reatment for urticaria should be second generation, non-sedating H.-antihistamines. Because, standard licensed doses of H.-antihistamines are often ineffective in completely relieving symptoms in many patients the guidelines suggest updosing second generation H.-antihistamines up to four-fold in pat
45#
發(fā)表于 2025-3-29 07:53:59 | 只看該作者
46#
發(fā)表于 2025-3-29 12:19:40 | 只看該作者
Other Interventions for Chronic Urticaria,atients to be highly effective for severe chronic urticaria, but have not been studied systematically because clinical experience shows they work. On the other hand, well-known adverse effects limit their use to short-term rescue therapy. Low-evidence interventions are still of value today if applie
47#
發(fā)表于 2025-3-29 16:09:10 | 只看該作者
Urticaria Therapy and Management. Looking Forward,n affirm with forcefulness that the most recent pathogenic and therapeutic advances in urticaria are constituted in a true revolution. Currently, the expectations of therapeutic success for the patient and for the doctor are frankly much better than 10?years before and will be even better in the imm
48#
發(fā)表于 2025-3-29 21:43:12 | 只看該作者
49#
發(fā)表于 2025-3-30 01:41:27 | 只看該作者
50#
發(fā)表于 2025-3-30 06:05:17 | 只看該作者
M. Greaves,Torsten Zuberbiert. Such a point of departure calls for a consistent spirit of cooperation with regard to the problems involved. This alone satisfies the initial requirement of simultaneously considering both the somatic and psychosocial aspects of health and illness.978-3-540-54556-9978-3-642-76940-5
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 20:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
安宁市| 梁河县| 清水县| 交城县| 诸城市| 墨玉县| 濉溪县| 铜梁县| 吉木萨尔县| 盱眙县| 昭觉县| 泾源县| 长治市| 克什克腾旗| 邛崃市| 页游| 高阳县| 黄骅市| 从江县| 湛江市| 榆中县| 大足县| 海宁市| 宽甸| 内江市| 福建省| 尉犁县| 辉县市| 苏尼特左旗| 凭祥市| 应城市| 北安市| 安顺市| 鄂温| 扶余县| 铜陵市| 潍坊市| 老河口市| 元江| 循化| 隆德县|